Cargando…

Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases

Denosumab has been used successfully to treat disease‐associated osteoclast overactivity, including giant cell tumor of bone. Given its mechanism of action, denosumab is a potent potential treatment of other osteoclast bone dysplasias including central giant cell granuloma (CGCG), aneurysmal bone cy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Upfill‐Brown, Alexander, Bukata, Susan, Bernthal, Nicholas M, Felsenfeld, Alan L, Nelson, Scott D, Singh, Arun, Wesseling‐Perry, Katherine, Eilber, Fritz C, Federman, Noah C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820455/ https://www.ncbi.nlm.nih.gov/pubmed/31687646 http://dx.doi.org/10.1002/jbm4.10210

Ejemplares similares

Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes
por: Shurell, Elizabeth, et al.
Publicado: (2016)

Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature
por: Giustini, Nicholas, et al.
Publicado: (2018)

Osteoclast Recycling and the Rebound Phenomenon Following Denosumab Discontinuation
por: Kim, Albert S., et al.
Publicado: (2022)

[(18)F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
por: Polverari, Giulia, et al.
Publicado: (2020)

Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum
por: Bukata, Susan V., et al.
Publicado: (2021)

Extension of the therapeutic spectrum in castration-resistant prostate cancer: Osteoclast inhibition with denosumab
por: Wolff, Johannes M., et al.
Publicado: (2012)

Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
por: Palmerini, Emanuela, et al.
Publicado: (2021)

Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma
por: Valle, Luca F., et al.
Publicado: (2021)

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
por: Kong, Sung Hye, et al.
Publicado: (2022)

Regression of fibrous dysplasia in response to denosumab therapy: A report of two cases
por: Meier, Maartje E., et al.
Publicado: (2021)

Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma
por: Shurell, Elizabeth, et al.
Publicado: (2016)

Denosumab as a potential therapeutic option for leiomyosarcoma with osteoclast-like giant cells: A case report
por: Sasaki, Taro, et al.
Publicado: (2018)

Successful treatment with denosumab for pelvic fibrous dysplasia: A case report and review of the literature
por: Ikuta, Kunihiro, et al.
Publicado: (2021)

Safety and Efficacy of Stereotactic Body Radiation Therapy in the Treatment of Pulmonary Metastases from High Grade Sarcoma
por: Mehta, Niraj, et al.
Publicado: (2013)

Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune‐Albright syndrome: an observational study
por: Meier, Maartje E., et al.
Publicado: (2021)

Anti-osteoclastic agent, denosumab, for a giant cell tumor of the bone with concurrent Paget's disease: A case report
por: Tanaka, Takaaki, et al.
Publicado: (2017)

Denosumab Can Prevent Collapse in Patients with Early‐Stage Steroid‐Induced Osteonecrosis of the Femoral Head by Inhibiting Osteoclasts and Autophagy
por: Liu, Bo, et al.
Publicado: (2022)

Racial disparities in post-operative complications and discharge destination following total joints arthroplasty: a national database study
por: Upfill-Brown, Alex, et al.
Publicado: (2022)

Aggressive osteoblastoma with a secondary aneurysmal bone cyst treated with denosumab
por: Wong, Karlton, et al.
Publicado: (2021)

Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients
por: Shurell, Elizabeth, et al.
Publicado: (2014)

Personalized chordoma organoids for drug discovery studies
por: Al Shihabi, Ahmad, et al.
Publicado: (2022)

COVID pandemic and denosumab adherence
por: Minisola, S., et al.
Publicado: (2022)

Denosumab: mechanism of action and clinical outcomes
por: Hanley, D A, et al.
Publicado: (2012)

Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman, Ursa, et al.
Publicado: (2013)

Denosumab for the treatment of osteoporosis
por: McClung, Michael R.
Publicado: (2017)

Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019)

Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022)

Denosumab and muscle performance
por: Rolvien, Tim, et al.
Publicado: (2022)

Giant-cell tumor of bone: treatment options and role of denosumab
por: Singh, Arun S, et al.
Publicado: (2015)

Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis
por: Taylor-Miller, Tashunka, et al.
Publicado: (2020)

The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension
por: Bone, Henry G., et al.
Publicado: (2013)

Fibroblast Activation Protein Expression in Sarcomas
por: Crane, Jacquelyn N., et al.
Publicado: (2023)

Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug
por: Murakami, Takashi, et al.
Publicado: (2016)

Denosumab and atypical femoral fractures
por: Aspenberg, Per
Publicado: (2014)

Denosumab: A comprehensive review
por: Narayanan, Prasad
Publicado: (2013)

Denosumab-Induced Immune Hepatitis
por: Ostrovsky, Viviana, et al.
Publicado: (2021)

Craniometaphyseal Dysplasia Mutations in ANKH Negatively Affect Human Induced Pluripotent Stem Cell Differentiation into Osteoclasts
por: Chen, I-Ping, et al.
Publicado: (2017)

The Friedman-Eilber Resection Arthroplasty of the Pelvis
por: Schwartz, Adam J., et al.
Publicado: (2009)

Lower Rates of Ceramic Femoral Head Use in Non-White Patients in the United States, a National Registry Study
por: Upfill-Brown, Alexander M., et al.
Publicado: (2022)

Molecular pathogenesis of desmoid tumor and the role of γ-secretase inhibition
por: Federman, Noah
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tlena5s2auk93vb0eeu0is9251